Creative Biolabs

Creative Biolabs is a biotechnology research company headquartered in the United States that provides comprehensive contract research organization (CRO) services for drug discovery and development. The company specializes in recombinant antibody discovery, engineering, and manufacturing, leveraging advanced technological platforms such as phage display, hybridoma technology, and genetic engineering. They offer an extensive portfolio that includes monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and cellular and gene therapy products. By utilizing custom-service-centered business models and state-of-the-art technique platforms, the company supports the full research and development pipeline, ranging from early target identification and validation to preclinical testing, process development, and cGMP manufacturing.

The company serves a global customer base spanning pharmaceutical companies, biotechnology firms, government research laboratories, and academic institutions. Their specialized services are designed to help researchers accelerate drug discovery, reduce development costs, and address complex therapeutic challenges in areas such as oncology and neurology. Through the provision of ready-to-use research products and integrated, one-stop custom services, Creative Biolabs acts as a strategic partner in the advancement of novel medicines. Their expertise is utilized to facilitate various stages of the development lifecycle, ensuring that researchers have access to the necessary biological tools and validated models to advance their projects from the laboratory to clinical readiness.